Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.67 +0.11 (+0.15%)
At close: Oct 20, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)

Updated

Ani Pharmaceuticals (ANIP) reported Notes Payables of $1.23 million for Q3 2011, up 3.9% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends

At the end of FY2010, Ani Pharmaceuticals posted Notes Payables of $1.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Ani Pharmaceuticals 1.54 Bn 315.85 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 1.23 Mn
Jun 30, 2011 1.19 Mn
Dec 31, 2010 1.11 Mn
API Access

Ani Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ANIP&period=max&api_key=YOUR_API_KEY